Abiopharma

News list

Shukla Sanjay 🟢 acquired 1.5M shares (1 derivative) of aTYR PHARMA INC (ATYR) at $0.71 ($1.1M) Transaction Date: Jan 09, 2026 | Filing ID: 009161

Full text

News bot Jan. 9, 2026, 10:47 p.m.
🔍 Shukla Sanjay (Executive)

Company: aTYR PHARMA INC (ATYR)

Report Date: 2026-01-09
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 1,500,000
Detailed Transactions and Holdings:
- Acquired 1,500,000 shares of Employee Stock Option (right to buy) at $0.7127 per share (Derivative)
  Date: 2026-01-09 | Code: A | Expires: 2036-01-09 | equity_swap_involved: false | shares_owned_after: 1,500,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning February 9, 2026, such that this option will be fully exercisable on January 9, 2029. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.